Chongqing, China

Mingyang Hou

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mingyang Hou. Retrieved from https://idiyas.com/inventor/mingyang-hou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 29.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mingyang Hou

Introduction

Mingyang Hou is a notable inventor based in Chongqing, China. He has made significant contributions to the field of medicine, particularly through his innovative work on polyethylene glycol conjugated drugs. His research and inventions have the potential to impact pharmaceutical applications significantly.

Latest Patents

Mingyang Hou holds a patent for a polyethylene glycol conjugate drug, along with its preparation method and use. This invention relates to the technical field of medicines and focuses on a polyethylene glycol conjugated drug, as well as a pharmaceutically acceptable salt thereof. The patent outlines a method for preparing the drug and its use in pharmaceutical compositions.

Career Highlights

Mingyang Hou is associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation in drug formulation and delivery systems.

Collaborations

Mingyang collaborates with talented individuals in his field, including Gaoquan Li and Dajun Li. Their combined expertise fosters a productive environment for research and development.

Conclusion

Mingyang Hou's contributions to the field of medicine through his innovative patent demonstrate his dedication to advancing pharmaceutical science. His work is poised to make a lasting impact on drug development and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…